Clinical trial units and clinical research coordinators: a system facing crisis?
Keywords:Clinical Research, Clinical Research Coordinator, Clinical Trial Management, Clinical Trial Unit
We are currently witnessing an increase in procedural and managerial complexities within the field of clinical research, which require greater human and infrastructural resources as well as imply the need for a greater skill set and expertise on the part of professionals. Within this frame of reference clinical trial units and clinical research coordinators play a vital role in the design and conduct of clinical trials in Italy. There is a current recruitment and retention crisis for this specialist role due to a complex set of factors, most likely to have come to a head due to the lack of recognition at the Italian institutional level, that lead to precarious work contracts, lack of identity, and excessive turnover at experimental sites. This article, led by the Italian Group of Clinical Research Coordinator (GIDMcrc), presents some of the issues and ways in which national stakeholders may be able to address this.
Cagnazzo C, Besse MG, Manfellotto D, et al. Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future? Tumori. 2021 Feb;107(1):6-11. https://doi.org/10.1177/0300891620977916 PMID: 33297885 DOI: https://doi.org/10.1177/0300891620977916
Tavazzi L, Maggioni AP, Rapezzi C, Ferrari R. One year on: the impact of COVID-19 on clinical research. Eur J Intern Med. 2021;92:24-27. https://doi.org/10.1016/j.ejim.2021.08.008PMID:34483019 DOI: https://doi.org/10.1016/j.ejim.2021.08.008
Malik L, Lu D. Increasing complexity in oncology phase I clinical trials. Invest New Drugs. 2019;37(3):519-523. https://doi.org/10.1007/s10637-018-0699-1 PMID:30443782 DOI: https://doi.org/10.1007/s10637-018-0699-1
Getz KA, Campo RA. Trial watch: trends in clinical trial design complexity. Nat Rev Drug Discov. 2017;16(5):307. https://doi.org/10.1038/nrd.2017.65 PMID:28417986 DOI: https://doi.org/10.1038/nrd.2017.65
Determina AIFA 809 del 19 giugno 2015 - Determina inerente i requisiti minimi necessari per le strutture sanitarie che eseguono sperimentazioni di fase I (GU Serie Generale n. 158 del 10.07.2015) https://www.gazzettaufficiale.it/eli/id/2015/07/10/15A05315/sg. Accessed October 2022.
Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0536. Accessed October 2022.
Perez-Gracia JL, Awada A, Calvo E, et al. ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy. ESMO Open. 2020;5(3):e000662. https://doi.org/10.1136/esmoopen-2019-000662 PMID:32393574 DOI: https://doi.org/10.1136/esmoopen-2019-000662
Park JJH, Siden E, Zoratti MJ, et al. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials. 2019;20(1):572. https://doi.org/10.1186/s13063-019-3664-1 PMID:31533793 DOI: https://doi.org/10.1186/s13063-019-3664-1
Croghan IT, Viker SD, Limper AH, et al. Developing a clinical trial unit to advance research in an academic institution. Contemp Clin Trials. 2015 Nov;45(Pt B):270-276. https://doi.org/10.1016/j.cct.2015.10.001 PMID: 26454064 DOI: https://doi.org/10.1016/j.cct.2015.10.001
von Niederhäusern B, Magnin A, Pauli-Magnus C. The impact of clinical trial units on the value of clinical research in Switzerland. Swiss Med Wkly. 2018;148:w14615. PMID:29698540 DOI: https://doi.org/10.4414/smw.2018.14615
ALTEMS. Il Valore delle sperimentazioni cliniche in Italia - Report 2020. https://altems.unicatt.it/altems-ricerca-il-valore-delle-sperimentazioni-cliniche-in-italia. Accessed October 2022.
Cinefra M, Cagnazzo C, McMahon L, et al. The critical role of the clinical research coordinator for clinical trials: a survey in oncology. Medicine Access @ Point of Care. 2017;1. doi:10.5301/maapoc.0000015 DOI: https://doi.org/10.5301/maapoc.0000015
Cagnazzo C, Testoni S, Guarrera AS, et al. [Clinical research coordinators: a crucial resource.] Recenti Prog Med. 2019;110(2):65-67. PMID:30843530
Martucci M, Guarrera A, Valente D, Resente F, Cagnazzo C. [Clinical research nurse in Italian centers: a mandatory figure?] Recenti Prog Med. 2020;111(9):535-538. PMID:32914783
Fujiwara N, Ochiai R, Shirai Y, et al. Qualitative analysis of clinical research coordinators’ role in phase I cancer clinical trials. Contemp Clin Trials Commun. 2017;8:156-161. https://doi.org/10.1016/j.conctc.2017.09.009 PMID:29696205 DOI: https://doi.org/10.1016/j.conctc.2017.09.009
Rico-Villademoros F, Hernando T, Sanz JL, et al. The role of the clinical research coordinator—data manager—in oncology clinical trials. BMC Med Res Methodol. 2004;4(1):6. https://doi.org/10.1186/1471-2288-4-6 PMID:15043760 DOI: https://doi.org/10.1186/1471-2288-4-6
Testoni S, Cenna R, Guarrera ASE, et al. Researchers’ pyramid. A new opportunity for Italian oncology research infrastructure? Ann Res Oncol. 2021;1:13-23. https://doi.org/10.48286/aor.2021.03 DOI: https://doi.org/10.48286/aor.2021.03
Mitchell EJ, Goodman K, Wakefield N, et al; UK Trial Managers’ Network. Clinical trial management: a profession in crisis? Trials. 2022;23(1):357. https://doi.org/10.1186/s13063-022-06315-8 PMID:35477835 DOI: https://doi.org/10.1186/s13063-022-06315-8
How to Cite
Copyright (c) 2023 Stefano Stabile, Rosita Cenna, Valentina Sinna, Franchina Veronica, Francesca Mannozzi, Irene Federici, Sara Testoni, Celeste Cagnazzo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to AboutOpen agree to publish their articles under the Creative Commons NonCommercial 4.0 International License (CC BY-NC 4.0), which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.